Mode
Text Size
Log in / Sign up
N/A N=120 Randomized Single-blind Treatment

Endometrial Injury for Unexplained Infertility

Infertility

Enrolled (actual)
120
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcome: Primary: Measurement of Uterine Artery Pulsatility Index — 2.40; 2.35 index — p=<0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
endometrial injury (Device)
Age
Adult · 20+ yrs
Sex
Female
Sponsor
Benha University
Primary completion
Feb 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Measurement of Uterine Artery Pulsatility Index
2.40; 2.35 <0.05 sig
PRIMARY
Measurement of Uterine Artery Resistance Index
0.86; 0.85 <0.05 sig
PRIMARY
Appearance of Sub Endometrial Blood Flow in All Patients
33; 12 <0.05 sig
PRIMARY
Spiral Artery Pulsatility Indices in All Patients
1.19; 1.01 <0.05 sig
PRIMARY
Spiral Artery Doppler Resistance Indices in All Patients
0.62; 0.66 <0.05 sig
SECONDARY
Pregnancy Rate Between the Study and the Control Group
11; 4 <0.05 sig

Summary

One hundred and twenty women with unexplained infertility were included in the study. Divided randomly into two groups: Group I: (60 patients): (control group) Group II (60 patients): (study group) All the patients received (CC) and human menopausal gonadotropin. On day 5 of the cycle, Doppler examination was performed to all patients. Also on day 5, but only for group (II) patients, local endometrial injury was performed. Doppler studies was repeated, for all our patients, on the same day of prescribing human chorionic gonadotropin

Eligibility Criteria

Inclusion Criteria

  • age Between 20 - 35 years
  • Body mass index 18-29 kg/m2
  • primary infertility for more than two years, and planning for IVF/intracytoplasmic sperm injection trial
  • Normal ovulation confirmed by previous US
  • Normal hormonal profile follicle stimulating hormone, luteinizing hormone, and prolactin, Antimullerian hormone (AMH) more than 1 ng/ml
  • Normal hysterosalpingography
  • Normal laparoscopic finding
  • normal semen analysis, according to World Health Organization 2010

Exclusion Criteria

  • Absence of inclusion criteria
  • History of previous laparotomy
  • Patients with history which may suggest endometriosis
  • Associated chronic medical conditions e.g. cardiac disease, diabetes, renal disease… etc.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02863198). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search